Mild Cognitive Impairment Clinical Trial
— CARBOfficial title:
Cognitive and Aerobic Resilience for the Brain
Verified date | March 2023 |
Source | Indiana University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a randomized controlled trial (RCT) of the effectiveness of cognitive and exercise training versus control condition on cognitive function in older adults with mild cognitive impairment (MCI).
Status | Completed |
Enrollment | 201 |
Est. completion date | October 25, 2019 |
Est. primary completion date | October 25, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: - subjective memory complaint - minimal impairment in daily function per Functional Activity Questionnaire (FAQ) - sedentary - English speaking - access to telephone Exclusion Criteria: - dementia or Alzheimer disease - stroke, past 12 months - myocardial infarction, past 12 months - angina - Parkinson disease - multiple sclerosis - epilepsy - AIDS - brain tumor, infection, or surgery - brain injury with > 30 minute LOC - schizophrenia - bipolar disorder - cancer with short life expectancy - current chemotherapy or radiation therapy - depression - alcohol consumption = 8 drinks per week for women, or =15 drinks per week for men - prescription of Aricept or Namenda, past or present - self-reported difficulty reading a newspaper (low visual acuity) - low hearing or communicative ability (examiner-rated) that would interfere with interventions and outcome assessments - prior involvement in similar cognitive training studies, programs, or online training - prior use of online brain training or brain fitness programs - unable to pass the Exercise Assessment and Screening for You (EASY) - living in nursing home - scheduling conflicts with intervention schedule - unwilling to use a computer or be on video conferencing - Baseline blood pressure of Systolic > 180 - Baseline blood pressure of Diastolic > 100 - Baseline pulse of < 40 or > 100 - unable to provide informed consent |
Country | Name | City | State |
---|---|---|---|
United States | Indiana University | Indianapolis | Indiana |
Lead Sponsor | Collaborator |
---|---|
Indiana University | National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cognitive function composite score as measured by individually-administered tests of psychomotor speed, complex sequencing, and list learning. | The cognitive composite is derived from: WAIS-IV Symbol Search, Trail Making Test Part B, and Rey Auditory Verbal Learning Test. | End of treatment at 12-weeks. | |
Primary | Average participant self-ratings of intervention acceptability. | Average of individual Likert self-ratings of the interventions (where 1 = very unenjoyable, 2 = not enjoyable, 3 = neutral, 4 = enjoyable, and 5 = very enjoyable) for each session of the 12-week intervention. | From date of randomization until the date of the final training session or the end of the 12-week intervention, whichever came first. | |
Primary | Participant adherence to treatment. | Number of training sessions attended divided by the the total number of sessions available. | From date of randomization until the date of the final training session or the end of the 12-week intervention, whichever came first. | |
Primary | Participant adherence to outcome assessment. | Number of participants completing the post-training outcome assessment divided by the total number randomized. | End of treatment at 12-weeks. | |
Primary | Number of participants with study-related adverse events (AE) by treatment arm. | From enrollment through end of treatment at 12-weeks. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |